Screening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases

The wide spectrum of COVID-19 symptoms complicates the selection of target groups for screening. We aimed to compare data of children screened for COVID-19 at the pediatric emergency department in Vilnius between different phases throughout 1 year (Phase I: March–May, 2020; Phase II: June–September,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Indrė Stacevičienė, Sigita Burokienė, Aušra Steponavičienė, Daiva Vaičiūnienė, Roma Puronaitė, Augustina Jankauskienė
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	COVID-19 SARS-CoV-2 children screening PCR pediatric emergency department Pediatrics RJ1-570
Acceso en línea:	https://doaj.org/article/7836611a99144ba2876088316e3d03d2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7836611a99144ba2876088316e3d03d2
record_format	dspace
spelling	oai:doaj.org-article:7836611a99144ba2876088316e3d03d22021-11-05T16:08:22ZScreening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases2296-236010.3389/fped.2021.749641https://doaj.org/article/7836611a99144ba2876088316e3d03d22021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fped.2021.749641/fullhttps://doaj.org/toc/2296-2360The wide spectrum of COVID-19 symptoms complicates the selection of target groups for screening. We aimed to compare data of children screened for COVID-19 at the pediatric emergency department in Vilnius between different phases throughout 1 year (Phase I: March–May, 2020; Phase II: June–September, 2020; and Phase III: October, 2020–February, 2021) and to evaluate the possible predictors of the disease. SARS-CoV-2 PCR tests were positive for 2.7% of tested children (248/9,238), significantly higher during the Phase III (5.5%) compared with the Phase I (0.6%, p = 0.000) and Phase II (0.3%, p = 0.000). Infants and teenagers (12–17 years) accounted for a larger proportion of COVID-19 patients (24.6 and 26.2%, respectively) compared to other age groups: 1–2 years (18.9%), 3–6 years (14.9%), and 7–11 years (15.3%). There were more COVID-19 cases among children with a known SARS-CoV-2 exposure compared to those who did not declare any contact (18.2 vs. 1.1%, p = 0000). When symptoms were adjusted for age, gender and known exposure to SARS-CoV-2, we found that fever (OR 2.66; 95% CI 1.89–3.81), pharyngitis (OR 1.35; 95% CI 1.01–1.80), headache (OR 1.81; 95% CI 1.09–2.90), and anosmia/ageusia (OR 6.47; 95% CI 1.61–22.47) were the most significant predictors.Conclusion: Although high numbers of testing were maintained throughout the year, the positive test results were significantly higher during the Phase III. Age (<1 year, 12–17 years), a history of exposure to SARS-CoV-2 and some symptoms, such as fever, pharyngitis, headache and anosmia/ageusia could aid in targeting groups for screening for COVID-19 in children.Indrė StacevičienėSigita BurokienėAušra SteponavičienėDaiva VaičiūnienėRoma PuronaitėAugustina JankauskienėFrontiers Media S.A.articleCOVID-19SARS-CoV-2childrenscreeningPCRpediatric emergency departmentPediatricsRJ1-570ENFrontiers in Pediatrics, Vol 9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 SARS-CoV-2 children screening PCR pediatric emergency department Pediatrics RJ1-570
spellingShingle	COVID-19 SARS-CoV-2 children screening PCR pediatric emergency department Pediatrics RJ1-570 Indrė Stacevičienė Sigita Burokienė Aušra Steponavičienė Daiva Vaičiūnienė Roma Puronaitė Augustina Jankauskienė Screening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases
description	The wide spectrum of COVID-19 symptoms complicates the selection of target groups for screening. We aimed to compare data of children screened for COVID-19 at the pediatric emergency department in Vilnius between different phases throughout 1 year (Phase I: March–May, 2020; Phase II: June–September, 2020; and Phase III: October, 2020–February, 2021) and to evaluate the possible predictors of the disease. SARS-CoV-2 PCR tests were positive for 2.7% of tested children (248/9,238), significantly higher during the Phase III (5.5%) compared with the Phase I (0.6%, p = 0.000) and Phase II (0.3%, p = 0.000). Infants and teenagers (12–17 years) accounted for a larger proportion of COVID-19 patients (24.6 and 26.2%, respectively) compared to other age groups: 1–2 years (18.9%), 3–6 years (14.9%), and 7–11 years (15.3%). There were more COVID-19 cases among children with a known SARS-CoV-2 exposure compared to those who did not declare any contact (18.2 vs. 1.1%, p = 0000). When symptoms were adjusted for age, gender and known exposure to SARS-CoV-2, we found that fever (OR 2.66; 95% CI 1.89–3.81), pharyngitis (OR 1.35; 95% CI 1.01–1.80), headache (OR 1.81; 95% CI 1.09–2.90), and anosmia/ageusia (OR 6.47; 95% CI 1.61–22.47) were the most significant predictors.Conclusion: Although high numbers of testing were maintained throughout the year, the positive test results were significantly higher during the Phase III. Age (<1 year, 12–17 years), a history of exposure to SARS-CoV-2 and some symptoms, such as fever, pharyngitis, headache and anosmia/ageusia could aid in targeting groups for screening for COVID-19 in children.
format	article
author	Indrė Stacevičienė Sigita Burokienė Aušra Steponavičienė Daiva Vaičiūnienė Roma Puronaitė Augustina Jankauskienė
author_facet	Indrė Stacevičienė Sigita Burokienė Aušra Steponavičienė Daiva Vaičiūnienė Roma Puronaitė Augustina Jankauskienė
author_sort	Indrė Stacevičienė
title	Screening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases
title_short	Screening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases
title_full	Screening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases
title_fullStr	Screening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases
title_full_unstemmed	Screening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases
title_sort	screening for coronavirus disease 2019 (covid-19) at the pediatric emergency department during different pandemic phases
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/7836611a99144ba2876088316e3d03d2
work_keys_str_mv	AT indrestaceviciene screeningforcoronavirusdisease2019covid19atthepediatricemergencydepartmentduringdifferentpandemicphases AT sigitaburokiene screeningforcoronavirusdisease2019covid19atthepediatricemergencydepartmentduringdifferentpandemicphases AT ausrasteponaviciene screeningforcoronavirusdisease2019covid19atthepediatricemergencydepartmentduringdifferentpandemicphases AT daivavaiciuniene screeningforcoronavirusdisease2019covid19atthepediatricemergencydepartmentduringdifferentpandemicphases AT romapuronaite screeningforcoronavirusdisease2019covid19atthepediatricemergencydepartmentduringdifferentpandemicphases AT augustinajankauskiene screeningforcoronavirusdisease2019covid19atthepediatricemergencydepartmentduringdifferentpandemicphases
_version_	1718444169368698880

Screening for Coronavirus Disease 2019 (COVID-19) at the Pediatric Emergency Department During Different Pandemic Phases

Ejemplares similares